This study analyzed data from the Trial to Assess Chelation Therapy (TACT) to evaluate whether edetate disodium chelation therapy provided different cardiovascular benefits based on the hypoglycemic treatment used by post-myocardial infarction (MI) patients with diabetes. Among 631 diabetic patients, those receiving insulin therapy experienced a significant reduction in major